ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
INNATE PHARMA: ifrs:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
One fact, its scope and the complete path back to the official record.
Reported value
-22.919M{"amount": -22919000.0}- Entity
- INNATE PHARMA
- Metric
- ifrs:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
- Period
- 2020-01-01 – 2020-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:9695002Y8420ZB8HJE29:2021-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T01:40:47.803569+02:00
Raw response SHA-256
42626ba7b8f480e2f866e4e74f892a57…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.